In the BioHarmony Drug Report Database

"Preview" Icon

Clascoterone

Winlevi (clascoterone) is a small molecule pharmaceutical. Clascoterone was first approved as Winlevi on 2020-08-26. The pharmaceutical is active against androgen receptor. Winlevi’s patents are valid until 2030-07-25 (FDA).

 

Trade Name

 

Winlevi
 

Common Name

 

clascoterone
 

ChEMBL ID

 

CHEMBL3590187
 

Indication

 

 

Drug Class

 

Antiandrogens

Image (chem structure or protein)

Clascoterone structure rendering